Vanda Pharmaceuticals (VNDA) Insider & Congress Trades

Smart money at a glance

Filings to Oct 31, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, quarter ended Jun 30, 2026: 1 added, 0 cutMore adding

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about VNDA filings

Are insiders buying or selling Vanda Pharmaceuticals Inc (VNDA) stock?

Neither. Vanda Pharmaceuticals Inc (VNDA) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded VNDA recently?

None. No member of Congress disclosed a VNDA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this VNDA smart-money data?

This summary uses filings available on Oct 31, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on VNDA

Lean long1 source:
- Funds

Top traders
No tracked positions at the last update
Insiders
No recent insider filings found
Politicians
No recent politician filings found
Funds
Lean long3 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about VNDA filings

Are insiders buying or selling Vanda Pharmaceuticals Inc (VNDA) stock?

Neither. Vanda Pharmaceuticals Inc (VNDA) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded VNDA recently?

None. No member of Congress disclosed a VNDA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this VNDA smart-money data?

Funds

What funds are doing

3 moves · 6 mo

Buys/Adds$25.6M

Buys/Adds (3)

AQ
AQR
Q2 2026 13F
$10.3M
added
Signals like this: n=13770, 53% finished lower at D15, median -0.4% vs SPY -0.4%
AQ
AQR
Q1 2026 13F
$5.6M
added
SS
State Street
Q1 2026 13F
$9.7M
added

Unlock everything for $29/month

Unlock for $29/month

Reported Oct 28, 2026

Earnings came in 48.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Oct 28, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.37+48.61% beat

-$0.72 expected

Revenue

$69.8M

SEC filing

Next report

Estimated report: Nov 4, 2026, in 4 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Oct 28, 2026	-$0.37est. -$0.72	+48.61%beat	$69.8MSEC filing	+24.1%from $56.3M
Jun 30, 2026Reported Aug 5, 2026	-$1.04est. -$0.51	-103.92%miss	$50.5MSEC filing	-3.9%from $52.6M
Mar 31, 2026Reported May 6, 2026	-$0.82est. -$0.69	-18.84%miss	$51.7MSEC filing	+3.4%from $50.0M
Dec 31, 2025Reported Feb 11, 2026	-$2.39est. -$1.32	-81.06%miss	$57.2MYahoo Finance	No year-ago quarter
Sep 30, 2025Reported Oct 29, 2025	-$0.38est. -$0.45	+15.56%beat	$56.3MSEC filing	+18.1%from $47.7M
Jun 30, 2025Reported Jul 31, 2025	-$0.46est. -$0.36	-27.78%miss	$52.6MSEC filing	+4.2%from $50.5M
Mar 31, 2025Reported May 7, 2025	-$0.50est. -$0.60	+16.67%beat	$50.0MSEC filing	+5.4%from $47.5M
Dec 31, 2024Reported Feb 13, 2025	-$0.08est. -$0.11	+27.27%beat	$198.8M · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $4.46
52-wk high: $9.94
High: $4.64
52-wk low: $3.74
Low: $3.96
Prev close: $4.00
Mkt cap: $229.2M
ROE: -82.6%
Fwd P/E: 103.1x
Beta: 0.69
P/S: 1.0x
P/B: 1.2x
Profit margin: -119.9%
Op margin: -33.7%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -119.9%
Forward P/E: 103.09
Market cap: $229M

Valuation

P/S1.00
P/B1.23

Quality

Operating margin-33.7%
ROE-82.6%
ROA-22.6%

Growth

Beta0.69

Technicals

Price structure

This stock is under pressure, and looks oversold after a sharp drop.

Trend

Under pressure

0 / 100

RSI 14

27oversold

20D volatility

35%annualized

52-week range

$4.05

$3.74$9.94

20D support

$3.79recent floor

20D resistance

$4.85recent ceiling

Returns

5D +0.0%20D -15.8%60D -20.4%

Price vs moving averages

SMA20 -4.7%SMA50 -16.0%SMA200 -35.0%

Volume pace

1.08xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Oct 28, 2026

-$0.37est. -$0.72

+48.61%

$69.8MSEC filing

+24.1%from $56.3M

Jun 30, 2026Aug 5, 2026

-$1.04est. -$0.51

-103.92%

$50.5MSEC filing

-3.9%from $52.6M

Mar 31, 2026May 6, 2026

-$0.82est. -$0.69

-18.84%

$51.7MSEC filing

+3.4%from $50.0M

Dec 31, 2025Feb 11, 2026

-$2.39est. -$1.32

-81.06%

$57.2MYahoo Finance

No year-ago quarter

Sep 30, 2025Oct 29, 2025

-$0.38est. -$0.45

+15.56%

$56.3MSEC filing

+18.1%from $47.7M

Jun 30, 2025Jul 31, 2025

-$0.46est. -$0.36

-27.78%

$52.6MSEC filing

+4.2%from $50.5M

Mar 31, 2025May 7, 2025

-$0.50est. -$0.60

+16.67%

$50.0MSEC filing

+5.4%from $47.5M

Dec 31, 2024Feb 13, 2025

-$0.08est. -$0.11

+27.27%

$198.8M · FYSEC filing

No year-ago quarter

Vanda Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about VNDA filings

Smart money on VNDA

Questions about VNDA filings

What funds are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 48.6% above what analysts expected.

Estimated report: Nov 4, 2026, in 4 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Vanda Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about VNDA filings

Smart money on VNDA

Questions about VNDA filings

What funds are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 48.6% above what analysts expected.

Estimated report: Nov 4, 2026, in 4 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Vanda Pharmaceuticals Inc

Overview

Questions about VNDA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Vanda Pharmaceuticals Inc

Overview

Questions about VNDA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.